128 related articles for article (PubMed ID: 25124574)
1. SLC35B2 expression is associated with a poor prognosis of invasive ductal breast carcinoma.
Chim-ong A; Thawornkuno C; Chavalitshewinkoon-Petmitr P; Punyarit P; Petmitr S
Asian Pac J Cancer Prev; 2014; 15(15):6065-70. PubMed ID: 25124574
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNA-based screening tool for breast cancer.
Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of TNFAIP8 is associated with tumor aggressiveness and poor prognosis in patients with invasive ductal breast carcinoma.
Xiao M; Xu Q; Lou C; Qin Y; Ning X; Liu T; Zhao X; Jia S; Huang Y
Hum Pathol; 2017 Apr; 62():40-49. PubMed ID: 28087477
[TBL] [Abstract][Full Text] [Related]
4. Reduced mRNA expression levels of NFE2L2 are associated with poor outcome in breast cancer patients.
Wolf B; Goebel G; Hackl H; Fiegl H
BMC Cancer; 2016 Oct; 16(1):821. PubMed ID: 27770790
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive microRNA-34a inhibits breast cancer cell migration and invasion via targeting oncogenic TPD52.
Li G; Yao L; Zhang J; Li X; Dang S; Zeng K; Zhou Y; Gao F
Tumour Biol; 2016 Jun; 37(6):7481-91. PubMed ID: 26678891
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin, Snail and Hakai in epithelial cells isolated from the primary tumor and from peritumoral tissue of invasive ductal breast carcinomas.
Makdissi FB; Machado LV; Oliveira AG; Benvenuti TT; Katayama ML; Brentani MM; Osório CA; Mourão Netto M; Lyra EC; Carvalho F; Góes JC; Folgueira MA
Braz J Med Biol Res; 2009 Dec; 42(12):1128-37. PubMed ID: 19893985
[TBL] [Abstract][Full Text] [Related]
8. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
Salhab M; Patani N; Jiang W; Mokbel K
Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
[TBL] [Abstract][Full Text] [Related]
9. One-Step Nucleic Acid Amplification Assay for Detection of Axillary Lymph Node Metastases in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
Takamoto K; Shimazu K; Naoi Y; Shimomura A; Shimoda M; Kagara N; Kim SJ; Tamaki Y; Noguchi S
Ann Surg Oncol; 2016 Jan; 23(1):78-86. PubMed ID: 26152274
[TBL] [Abstract][Full Text] [Related]
10. A novel biomarker C6orf106 promotes the malignant progression of breast cancer.
Jiang G; Zhang X; Zhang Y; Wang L; Fan C; Xu H; Miao Y; Wang E
Tumour Biol; 2015 Sep; 36(10):7881-9. PubMed ID: 25953261
[TBL] [Abstract][Full Text] [Related]
11. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.
Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K
Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773
[TBL] [Abstract][Full Text] [Related]
12. Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients.
Duchnowska R; Jassem J; Goswami CP; Dundar M; Gökmen-Polar Y; Li L; Woditschka S; Biernat W; Sosińska-Mielcarek K; Czartoryska-Arłukowicz B; Radecka B; Tomasevic Z; Stępniak P; Wojdan K; Sledge GW; Steeg PS; Badve S
J Neurooncol; 2015 Mar; 122(1):205-16. PubMed ID: 25559688
[TBL] [Abstract][Full Text] [Related]
13. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
[TBL] [Abstract][Full Text] [Related]
14. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
Yin Y; Sanders AJ; Jiang WG
Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
[TBL] [Abstract][Full Text] [Related]
15. The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion.
Petrović N; Mandušić V; Stanojević B; Lukić S; Todorović L; Roganović J; Dimitrijević B
Med Oncol; 2014 Mar; 31(3):867. PubMed ID: 24488617
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of β -tubulin isotype III gene expression in breast cancer patients.
He Q; Peng B; Zhuang D; Xiao L; Zheng L; Fan Z; Zhu J; Xu B; Xu C; Zhao J; Wu L; Zhou P; Hou L; Yu F; Zhao G
Cancer Biomark; 2015; 15(6):823-31. PubMed ID: 26406408
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous ATM/BRCA1/RAD51 expression variations associated with prognostic factors in Iranian sporadic breast cancer patients.
Hallajian Z; Mahjoubi F; Nafissi N
Breast Cancer; 2017 Jul; 24(4):624-634. PubMed ID: 28058614
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.
Skondra M; Gkioka E; Kostakis ID; Pissimissis N; Lembessis P; Pectasides D; Koutsilieris M
Anticancer Res; 2014 Nov; 34(11):6691-9. PubMed ID: 25368276
[TBL] [Abstract][Full Text] [Related]
19. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
20. High expression of Rac1 is correlated with partial reversed cell polarity and poor prognosis in invasive ductal carcinoma of the breast.
Liu B; Xiong J; Liu G; Wu J; Wen L; Zhang Q; Zhang C
Tumour Biol; 2017 Jul; 39(7):1010428317710908. PubMed ID: 28671041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
